home / stock / avai / avai news

AVAI News and Press, Avant Technologies Inc. From 01/14/26

Stock Information
Company Name: Avant Technologies Inc.
Stock Symbol: AVAI
Market: OTC
Website: avanttechnologies.com
Menu
AVAI AVAI Quote AVAI Short AVAI News AVAI Articles AVAI Message Board
Get AVAI Alerts

News, Short Squeeze, Breakout and More Instantly...
AVAI - THE SOVEREIGN MANDATE: 5 Stocks Securing the 2026 Choke Points

VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com Market Intelligence Brief – The era of abundance has reached its limit. The speculative fever of the last decade has been replaced by a scramble for the "Choke Point." The physical and digital bottlenec...
AVAI - Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize

Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize Canada NewsWire Issued on behalf of Avant Technologies Inc. VANCOUVER, BC , Jan. 2, 2026 /CNW/ -- Equity Insider News Commentary – The gene therapy market is surging toward $36.55 billion by 2032,...

AVAI - The End of Shots? 5 Biotech Stocks Rethinking Diabetes

The End of Shots? 5 Biotech Stocks Rethinking Diabetes Canada NewsWire Issued on behalf of Avant Technologies Inc. VANCOUVER, BC , Dec. 31, 2025 /CNW/ -- USA News Group News Commentary – Recent clinical trials achieving 83% insulin independence rates have...

AVAI - THE FOUNDATION TRADE: 5 Assets Anchoring the Next Industrial Cycle

VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) -- USANewsGroup.com   Market Intelligence Brief – The AI trade is running out of runway. Not because technology failed, but because the market remembered that software runs on hardware, and hardware runs on holes in the...
AVAI - From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive d...

AVAI - Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy

Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy Canada NewsWire Issued on behalf of Avant Technologies Inc. Equity Insider News Commentary VANCOUVER, BC , Dec. 16, 2025 /CNW/ -- The cell therapy manufacturing sector reached a pivotal inflection ...

AVAI - Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment

Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment Canada NewsWire LAS VEGAS , Dec. 16, 2025 /CNW/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focus...
AVAI - THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis

VANCOUVER, British Columbia, Dec. 15, 2025 (GLOBE NEWSWIRE) -- USANewsGroup .com Market Intelligence Brief – The market is repricing risk around a single variable: detection. The most dangerous threats are the ones that cannot be seen. Hidden cardiac defects collaps...

AVAI - Avant Technologies and Austrianova Advancing ?-Klotho Cell Therapy as Mayo Clinic Study Links Low ?-Klotho Levels to Poor Cardiovascular Survival

2025-12-09 08:01:40 ET LAS VEGAS, NEVADA, December 9, 2025 – Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disord...

AVAI - THE CRITICAL LIST: 5 Stocks Anchoring the New Economy

Issued on behalf of Quantum Security Encryption Corp. VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- USANewsGroup .com Market Intelligence Brief – The market is in triage. Speculative growth multiples are collapsing. Cash-burning "disruptors" are...
Previous 10 Next 10